全文获取类型
收费全文 | 20448篇 |
免费 | 1633篇 |
国内免费 | 694篇 |
专业分类
耳鼻咽喉 | 39篇 |
儿科学 | 216篇 |
妇产科学 | 140篇 |
基础医学 | 839篇 |
口腔科学 | 139篇 |
临床医学 | 1486篇 |
内科学 | 2546篇 |
皮肤病学 | 276篇 |
神经病学 | 1876篇 |
特种医学 | 199篇 |
外国民族医学 | 1篇 |
外科学 | 748篇 |
综合类 | 2237篇 |
一般理论 | 3篇 |
预防医学 | 1175篇 |
眼科学 | 155篇 |
药学 | 8744篇 |
7篇 | |
中国医学 | 1265篇 |
肿瘤学 | 684篇 |
出版年
2024年 | 65篇 |
2023年 | 327篇 |
2022年 | 483篇 |
2021年 | 695篇 |
2020年 | 690篇 |
2019年 | 758篇 |
2018年 | 767篇 |
2017年 | 826篇 |
2016年 | 724篇 |
2015年 | 721篇 |
2014年 | 1448篇 |
2013年 | 2205篇 |
2012年 | 1308篇 |
2011年 | 1375篇 |
2010年 | 1104篇 |
2009年 | 906篇 |
2008年 | 853篇 |
2007年 | 883篇 |
2006年 | 730篇 |
2005年 | 656篇 |
2004年 | 544篇 |
2003年 | 532篇 |
2002年 | 379篇 |
2001年 | 363篇 |
2000年 | 282篇 |
1999年 | 240篇 |
1998年 | 223篇 |
1997年 | 215篇 |
1996年 | 212篇 |
1995年 | 187篇 |
1994年 | 155篇 |
1993年 | 187篇 |
1992年 | 182篇 |
1991年 | 137篇 |
1990年 | 131篇 |
1989年 | 106篇 |
1988年 | 116篇 |
1987年 | 75篇 |
1986年 | 87篇 |
1985年 | 127篇 |
1984年 | 113篇 |
1983年 | 82篇 |
1982年 | 92篇 |
1981年 | 61篇 |
1980年 | 70篇 |
1979年 | 55篇 |
1978年 | 63篇 |
1977年 | 56篇 |
1976年 | 47篇 |
1975年 | 43篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
161.
162.
Corsonello A Pedone C Corica F Malara A Carosella L Sgadari A Mauro VN Ceruso D Pahor M Carbonin P 《European journal of epidemiology》1999,15(10):893-901
We performed this case–control study to evaluate the risk of hypoglycemia associated with the use of antihypertensive drugs in older hospitalized diabetic patients treated with sulfonylureas and/or insulin. All diabetic patients admitted during 4 months in 1988, 1 month in 1991, 4 months in 1993 and 4 months in 1995 (n = 3477, mean age 71.4 ± 0.2 years, 1542 males and 1935 females) were enrolled in the study. During the four annual surveys 86 patients (mean age 71.1 ± 1.4 years, 33 males and 53 females) presented hypoglycemia during hospital stay. The patients who presented hypoglycemia were less frequently users of sulfonylureas and more frequently users of a combination of insulin and sulfonylureas. Use of antihypertensive drugs was similar in the two groups studied, and among potentially interacting drugs considered in the analysis, sulfonamides were more frequently used in patients who experienced hypoglycemia. Moreover, patients with hypoglycemia used a higher number of drugs, had a longer length of stay and had a greater prevalence of hypoglycemia as admission problem. Finally, although not significant, liver and renal diseases were more frequent among patients with hypoglycemia. In the multivariate analysis, contemporary use of insulin and sulfonylureas, liver disease and length of stay were significantly associated with hypoglycemia, while none of the antihypertensive drugs showed a significant association with the occurrence of hypoglycemia during hospital stay. Our results indicate that antihypertensive drugs do not increase the risk of hypoglycemia in elderly diabetic patients. 相似文献
163.
关于中医辛润法的理论思考 总被引:9,自引:0,他引:9
王殿华 《山东中医药大学学报》1999,23(3):169-172
探讨辛润源流,剖析辛味药物,指出辛味药在整体上不具备润养功效,不应与能散、能行相提并论。若把辛润理解为个别药物的润养作用,有失辛润之旨,更无法选药组方应用于临床。因此,当把辛润立之为法,即辛润法。燥证的发病机制,是外燥邪气、痰饮瘀血、气郁邪阻而致津血运行输布障碍,形体失却濡养。辛润机制,赖其辛味行散之功,宣肺祛邪,散饮化瘀,行气除滞,疏通腠理,布津行血而实现 相似文献
164.
Merlo J Lindberg G Lindblad U Lindgren A Råstam L Melander A 《European journal of clinical pharmacology》1999,55(1):69-76
Objective: To perform an ecological study in an effort to generate questions concerning the preventive impact of various cardiovascular
drugs on mortality from stroke and ischaemic heart disease (IHD) in the community, and to explore the association between
sales of nitrates and mortality from stroke and IHD.
Methods: Out-patient drug utilization (sales) of blood pressure lowering drugs, lipid lowering drugs and nitrates were categorized
in four groups of equal size by quartiles and compared with mortality from IHD and stroke, using the group of municipalities
with the lowest utilization as reference, from 1989 to 1993 in 283 of Sweden's 288 municipalities, by Poisson regression.
Adjustments were made for population size, age and gender proportions, the utilization rate of cardiovascular drugs other
than the tested drug group and location of the municipality.
Results: Compared with the group of municipalities with the lowest sales and adjusting only for population size, mortality from IHD
and stroke increased with the extent of utilization of blood pressure lowering drugs and nitrates. In contrast, mortality
decreased with increased utilization of lipid lowering drugs. After further adjustments by percentage of men, age structure,
geographical location (mid-points) of the municipalities, and, as a proxy for cardiovascular disease, the sales of cardiovascular
drugs other than the tested drug group, the increased risk associated with blood pressure lowering drugs disappeared, and
there was a dose-response association between sales of diuretics and old antihypertensives and decreasing mortality, sales
of nitrates continued to be associated with an increased risk, and the low mortality risk associated with sales of lipid lowering
drugs persisted.
Conclusion: Lipid lowering drugs may have a preventive impact in the general population, but the preventive impact of blood pressure
lowering drugs, with the exception of diuretics and old antihypertensives, may be low in many municipalities. The safety of
nitrates needs more investigation at the individual level.
Received: 16 April 1998 / Accepted in revised form: 10 November 1998 相似文献
165.
R. B. Dickson M. D. Johnson M. Maemura J. Low 《Breast cancer research and treatment》1996,38(1):121-132
Summary Most of the pharmaceuticals in clinical practice today for treatment of breast and other cancers are cytotoxic or cytostatic inhibitors of tumor growth. While this type of drug has found its place, along with surgery and radiotherapy, in treatment of disease, the breast cancer death rate has not decreased. This appears to be the result of rising incidence, resistance to therapy, and metastasis of the disease. Since distant metastasis (usually indicated by lymph node involvement) of breast cancer is related only indirectly to tumor size, it would appear that a concerted effort should be made to discover drugs which directly interfere with this complex process. Metastasis appears to depend upon tumor cell motility, dedifferen-tiation, local invasion, and angiogenesis. Significant progress has been recently made in the creation of new animal models of metastasis and in identifying several new drugs which may be suitable for clinical inhibition of this process. This article reviews current findings on anti-invasion/metastasis drugs with a focus on breast cancer.Presented at the symposium "New Approaches in the Therapy of Breast Cancer", Georgetown University Medical Center, Washington DC, October 1994, generously supported by an education grant from Bristol-Myers Squibb. 相似文献
166.
Background: The pharmacokinetic variables of drug clearance and volume of distribution are usually corrected for body weight
or surface area. Only recently have the relationships which exist between body size, physiologic function and pharmacokinetic
variables been evaluated in the obese population. These effects are not widely known, and data on this and the effects of
bariatric surgical procedures are scantily documented in the surgical literature. Methods: Literature review. Results: Drugs
with a low or moderate affinity for adipose tissue have a moderate increase in the volume of distribution (Vd), and this correlates
with the increase in lean body mass (LBM). Highly lipophilic drugs, with some exceptions, show the expected increase in Vd
and prolongation of elimination half-life, indicating a marked distribution into adipose tissue. Drug absorption, in general,
is slowed by delayed gastric emptying and is normal when gastric emptying is normal or increased. Most drug absorption occurs
in the small intestine where duration of drug/mucosal contact is the most important factor. Conclusions: Drugs whose distribution
is restricted to LBM should utilize a loading dose based on ideal body weight (IBW). For those drugs which distribute freely
into adipose tissue, the loading dose should be based on total body weight (TBW). Adjustment of the maintenance dose depends
on clearance rates. In a few cases dosage adjustment depends on pharmacodynamic data, since drug clearance does not conform
to these recommendations, for reasons which remain to be defined. Following bariatric surgery, in the absence of delayed gastric
emptying or uncontrolled diarrhea, drug absorption rates are usually comparable to the non-operated patient. 相似文献
167.
168.
B Beer C A Klepner A S Lippa R F Squires 《Pharmacology, biochemistry, and behavior》1978,9(6):849-851
SQ 65,396, a clinically active anti-anxiety agent, enhanced the binding of 3H-diazepam at 1.5 nM. This effect was due to an increase in the affinity for the ligand, without a change in the number of 3H-diazepam binding sites. This action of SQ 65,396 may mediate its anti-anxiety effects by affecting the action of an endogenous modulator of the "benzodiazepine receptor." Several other substances and treatments increase the affinity of 3H-diazepam for its receptors by mechanisms which may be related to the effect produced by SQ 65,396. 相似文献
169.
W. Fröscher M. Eichelbaum R. Gugler G. Hildenbrand H. Penin 《Journal of neurology》1981,224(3):193-201
Summary To evaluate whether knowledge of plasma levels of anti-epileptic drugs has an effect on therapeutic outcome, 127 epileptic outpatients were randomly assigned to two groups (A and B). Plasma levels of group A were reported to the treating physician who attempted to keep the plasma levels within the therapeutic range. The treating physician was not informed of the results of plasma lavel determinations of group B. Data from 105 patients were available for assessment at the end of the study year. Therapeutic results of groups A and B were not significantly different. The reduction in seizure frequency was associated with an increase in plasma concentrations of the anti-epileptic drugs. Thus, under the conditions of the study, knowledge of plasma levels of anti-epileptic drugs did not further improve therapeutic results.
Zusammenfassung Um festzustellen, ob die Kenntnis des Plasmaspiegels der Antiepileptika das Therapieergebnis verbessern kann, wurden 127 ambulant behandelte Patienten mit Epilepsie in randomisierter Reihenfolge in zwei Gruppen eingeteilt (A und B). Die Plasmaspiegel der Antiepileptika in Gruppe A wurden dem behandelnden Arzt mitgeteilt, der versuchen sollte, die Plasmaspiegel in den Therapeutischen Bereich zu bringen. Die Ergebnisse der Plasmaspiegelbestimmung in Gruppe B (Kontrollgruppe) wurden dem behandelnden Arzt nicht mitgeteilt. Am Ende des Untersuchungsjahres konnten die Daten von 105 Patienten ausgewertet werden. Das Behandlungsergebnis von Gruppe A und von Gruppe B war am Ende des Beobachtungsjahres nicht signifikant verschieden. Die Abnahme der Anfallshäufigkeit ging mit einem Anstieg der Plasmakonzentration der Antiepileptika einher. Somit konnte unter den Bedingungen dieser Studie das Therapieergebnis durch die Kenntnis der Plasmaspiegel der Antiepileptika nicht weiter verbessert werden.相似文献
170.
The objectives of this study were to describe the patterns of alcohol and recreational drug use of HIV-seropositive homosexual men and to determine the effect of alcohol use on HIV risk-taking behaviour. Of particular interest was the effect of knowledge of HIV status on these behaviours. Information on alcohol and drug use was obtained from 485 HIV-seropositive homosexual and bisexual men presenting to a HIV-antibody testing and medical management clinic. Heavy alcohol use was common, with 46.2% reporting consumption of six or more standard drinks on one day recently. Men who knew that they were HIV infected drank significantly more than those men who had yet to learn of their HIV status at the time of interview. There was clear evidence in this study for a role of alcohol use in HIV risk-taking behaviour. Almost one-third (27%) of the HIV-seropositive men reported unprotected anal intercourse during the previous 3 months with approximately one-third of these (27/76, 35·5%) nominating alcohol as contributing to their high HIV-risk behaviour. 相似文献